Serological markers for hepatocellular carcinoma (HCC) are important for early diagnosis,
as well as monitoring of tumour aggressiveness, treatment responsiveness, recurrence and …

Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumor. It is
usually asymptomatic in the early stages and tends to be intravascularly and intrabiliary …

Background The hepatocellular carcinoma is one of the most common malignant tumors and
carries a poor survival rate. The management of patients at risk for developing HCC remains …

Abstract Alpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3),
and protein induced by vitamin K absence or antagonist-II (PIVKA-II) are widely used as …

Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors and is the
second most common cause of cancer death in China. Therefore, it is very important to …

Abstract α‐Feto protein (AFP) is the widely used tumor marker in the diagnosis of
hepatocellular carcinoma (HCC). The aim of this study was to assess the diagnostic and …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some
areas of the world with increasing incidence worldwide. Most of patients with HCC are …

Results GPC-3 was the best marker with an area under the curve (AUC) of 0.892; using 26.8
ng/mL as the cut-off for HCC diagnosis, GPC-3 has a sensitivity of 51.5% and maintains a …

Abstract Backgrounds Glypican-3 (GPC3) has been reported as one of the most promising
serum markers for hepatocellular carcinoma (HCC), while several studies have conflicting …

Hepatocellular carcinoma (HCC) is one of the most recurrent and lethal cancers worldwide.
The low survival rate of this particular strain of carcinoma is largely due to the late stages at …